44 posts
Standard
Two individuals walking into a clinician’s office with a diagnosis of major depressive disorder may share the same clinical label, but their lived experiences can be worlds apart. One patient might grapple with the relentless cycle of repetitive negative thoughts and debilitating anxiety, while another may find themselves struggling with the long-term echoes of trauma…
Standard
By Shaun Heasley | October 8, 2026 The term "profound autism" has gained significant traction in recent years as a descriptive category for individuals situated on the more severe end of the autism spectrum. However, despite its growing usage across clinical, research, and advocacy spaces, the autism community has long grappled with a lack of…
Standard
By Shaun Heasley The term “profound autism” has steadily gained traction in recent years as a descriptive category for individuals on the most severe end of the autism spectrum. However, despite its widespread adoption in clinical discussions, public policy debates, and family advocacy networks, researchers and clinicians have struggled to agree on precise diagnostic boundaries.…
Standard
For decades, the clinical diagnosis of major depressive disorder has functioned as a broad umbrella, grouping millions of individuals under a single medical label. Yet, the lived experience of those suffering from the condition is notoriously varied. One patient may be paralyzed by relentless, repetitive negative thoughts and debilitating anxiety, while another may grapple with…
Standard
In a significant advancement for neuroscience, a team of researchers led by Professor Nicholas Barnes at the University of Birmingham has identified a promising new pathway to mitigate harmful inflammation in the brain. The study, published in the journal Brain, focuses on the P2X7 receptor—a protein that acts as a key driver of neuroinflammatory responses.…
Standard
In a significant advancement for neurological medicine, researchers at the University of Birmingham have unveiled a promising new strategy to curb harmful inflammation in the brain. By pinpointing a specific receptor—the P2X7 receptor—that acts as a primary catalyst for neuroinflammatory responses, the team has identified a potential therapeutic pathway that could be addressed using existing…
Standard
Why do some new skills seem to click almost instantly, becoming second nature after only a few attempts, while others remain frustratingly elusive, resisting even the most rigorous and repeated practice? For decades, scientists have attributed this discrepancy largely to innate talent, individual dedication, or the quality of instruction. However, a groundbreaking study suggests that…
Standard
In a significant stride toward understanding the biological underpinnings of Alzheimer’s disease, researchers at Mount Sinai have uncovered critical new evidence regarding how APOE4—the most potent genetic risk factor for the condition—triggers progressive brain damage. Two landmark studies, published concurrently in the journals Cell and Cell Stem Cell, provide a transformative look at how this…
Standard
The term "profound autism" has gained significant traction over the last several years, emerging as a shorthand way to describe individuals on the most severe end of the autism spectrum. While the phrase is intended to capture the reality of those with the highest support needs, its application has been hampered by a lack of…
Standard
The "profound autism" label has gained significant traction in recent years as a descriptive term for individuals on the more severe end of the autism spectrum. However, as the terminology becomes more widespread across medical, academic, and policy circles, a concerted effort is underway to clarify exactly who qualifies for the designation. The label first…
